Advocacy intelligence hub — real-time data for patient organizations
Institut National de la Santé Et de la Recherche Médicale, France — NA
Austedo: FDA approved
indicated in adults for the treatment of tardive dyskinesia
Seoul National University Hospital
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Ingrezza
(valbenazine)Orphan drugstandardNeurocrine Biosciences Inc.
12.1 Mechanism of Action The mechanism of action of valbenazine for the treatment of tardive dyskinesia and chorea in patients with Huntington’s disea...